{
  "id": 4653137,
  "title": "T cell therapy shows promise in treating aggressive brain cancer",
  "url": "https://urgent.news/2026/08/31/t-cell-therapy-shows-promise-in-treating-aggressive-brain-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T13:40:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-cell-therapy-aggressive-brain-cancer.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form of immunotherapy that modifies an individual's own T cells (a type of immune cell) so they are better able to recognize and destroy cancer cells. The new clinical trial, the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}